- Home
- RPRX vs WES Comparison
RPRX vs WES Comparison
Compare RPRX & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | WES |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 16.6B |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RPRX | WES |
|---|---|---|
| Price | $47.29 | $40.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $47.75 | $41.71 |
| AVG Volume (30 Days) | ★ 2.9M | 1.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 1.94% | ★ 9.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | $2,378,193,000.00 | ★ $3,843,403,000.00 |
| Revenue This Year | $38.30 | $7.04 |
| Revenue Next Year | $4.80 | $6.56 |
| P/E Ratio | $27.29 | ★ $14.73 |
| Revenue Growth | 5.06 | ★ 6.61 |
| 52 Week Low | $30.04 | $33.60 |
| 52 Week High | $49.06 | $44.74 |
Technical Indicators
Market Signals| Indicator | RPRX | WES |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 45.38 |
| Support Level | $44.84 | $39.48 |
| Resistance Level | $47.86 | $41.08 |
| Average True Range (ATR) | 0.92 | 0.88 |
| MACD | 0.11 | -0.08 |
| Stochastic Oscillator | 61.20 | 21.31 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About WES Western Midstream Partners LP
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.